Clarivate CLVT
- Market cap
- $1.2B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.5×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $2.4B
- −3% on a year ago
- Net margin
- −13.8%
- Free cash flow yield
- 27.4%
Clarivate trades at 0.5× sales. Its trailing earnings are negative, so it has no PE. Revenue was $2.4B over the last twelve months, down 3% on a year earlier with a −14% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $647.2M+2% | $683.7M+1% | $621.2M−1% | $650.3M−3% | $622.2M−4% | $663M−3% | $593.7M−4% | $621.4M−4% | $623.1M+0% | $617M−7% | $585.5M−1% | $587.3M−6% | |
| Cost of revenue | $220.6M−1% | $231.6M−2% | $217.8M−5% | $213.6M−5% | $210.1M−5% | $227.7M−2% | $207M−5% | $203.6M−5% | $218.2M+4% | $204.8M−10% | $192.1M−7% | $185.5M−9% |
| Gross profit | $426.6M+4% | $452.1M+3% | $403.4M+1% | $436.7M−2% | $412.1M−3% | $435.3M−4% | $386.7M−4% | $417.8M−4% | $404.9M−2% | $412.2M−5% | $393.4M+2% | $401.8M−4% |
| SG&A | $171.9M+1% | $180.4M−0% | $191.9M−2% | $185.2M−4% | $169.7M−1% | $180.8M+0% | $178.4M−7% | $181.1M−2% | $170M+0% | $179.1M−1% | $176.3M−1% | $181.6M+0% |
| $87.2M | −$788.2M | $5M−91% | −$240M+172% | $21.7M−75% | −$62.3M−92% | −$20.8M | $6.9M | $44M+103% | $41.4M | $30.2M | −$200.2M | |
| Interest expense | $71.9M+1% | $75.2M−2% | $70.2M−5% | $71.1M−3% | $72.2M+0% | $69.9M−7% | $64.3M−8% | $66.6M−6% | $68.5M−5% | $66M−6% | $59M−8% | $60.4M−9% |
| Pre-tax income | $27.9M | −$861.9M | −$60M+199% | −$311.1M+96% | −$50.5M | −$132.2M−85% | −$85.1M+42% | −$59.7M−81% | −$24.5M−52% | −$24.6M−81% | −$28.8M−66% | −$260.6M+337% |
| $15.6M−29% | −$18M−77% | $15M | −$6.8M−81% | $15.1M−3% | $59.6M | $18.8M+25% | $12.3M | $3.8M−75% | −$27.7M | $11.4M−39% | $8M−35% | |
| Net income | $12.3M | −$843.9M | −$75M | −$304.3M+147% | −$65.6M | −$191.8M−77% | −$103.9M+39% | −$72M−76% | −$28.3M−57% | $3.1M | −$40.2M−61% | −$268.6M+273% |
| −$0.01−100% | −$1.30 | −$0.14 | −$0.46+119% | −$0.09+800% | −$0.27−79% | −$0.15+7% | −$0.11−76% | −$0.04−56% | $0.00 | −$0.06−60% | −$0.42+282% | |
| 670.9M−1% | 664.8M−1% | 666.9M−2% | 685.6M+1% | 718.7M+7% | 702.8M+6% | 689.8M+3% | 681.3M−1% | 668.3M−7% | 654.3M−7% | 640.7M−7% | 639.4M−6% |
Gross profit: 30 periods, Q1 FY19 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 5 periods, Q4 FY19 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q4 FY19 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY20 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest Clarivate's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CLVTClarivate | $1.2B | n/m | 33.1× | 0.5× | −3% | −13.8% | |
| LZLegalzoom.Com | $1.2B | 77.7× | 68.5× | 1.5× | +12% | 2.1% | |
| GDRXGoodRx | $1.2B | 88.5× | 55.6× | 1.5× | −2% | 2.1% | |
| UPWKUpwork | $1.2B | 12.5× | 15.9× | 1.5× | +2% | 12.9% | |
| HSTMHealthstream | $1B | 48.8× | 54.3× | 3.2× | +9% | 6.6% | |
| EVEREverQuote | $801.4M | 7.4× | 18.5× | 1.1× | +23% | 15.2% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| EVTCEVERTEC | $1.9B | 21.1× | 20.9× | 1.9× | +12% | 9.8% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| INODInnodata | $2B | 45.0× | 70.4× | 6.4× | +39% | 14.7% | |
| Peer median | $1.1B | 29.9× | 37.3× | 1.6× | +12% | 9.3% |
More on Clarivate
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 71Application software stocks with the highest free cash flow yield
- #6of 345Technology stocks with the highest free cash flow yield
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .